IL10 and metabolic dysfunction-associated steatohepatitis: Therefore, treatment of anti‐inflammatory cytokine IL‐10 in 3T3‐L1 pre‐adipocytes or celecoxib in diabetic rat could suppress the adipogenesis and reverse the non‐alcoholic steatohepatitis (NASH) via targeting this non‐canonical Wnt5a pathway.79, 80